Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.
Saved in:
| Title: | Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia. |
|---|---|
| Authors: | Nguyen D; The University of Texas MD Anderson Cancer Center Houston United States., Kantarjian HM; The University of Texas MD Anderson Cancer Center Houston, Tx United States., Bidikian A; The University of Texas MD Anderson Cancer Center Houston, Tx United States., Manuel CM; The University of Texas MD Anderson Cancer Center United States., Qiao W; The University of Texas MD Anderson Cancer Center Houston, Texas United States., Ning J; The University of Texas MD Anderson Cancer Center Houston, TX United States., DiNardo CD; The University of Texas MD Anderson Cancer Center Houston, TX United States., Kadia TM; The University of Texas MD Anderson Cancer Center Houston, TX United States., Daver N; The University of Texas MD Anderson Cancer Center Houston, TX United States., Borthakur G; The University of Texas MD Anderson Cancer Center Houston, TX United States., Jabbour E; The University of Texas MD Anderson Cancer Center Houston, TX United States., Yilmaz M; The University of Texas MD Anderson Cancer Center Houston, Texas United States., Maiti A; The University of Texas MD Anderson Cancer Center Houston, TX United States., Sasaki K; Institute of Science Tokyo Houston, TX United States., Montalban-Bravo G; The University of Texas MD Anderson Cancer Center Houston, TX United States., Chien K; The University of Texas MD Anderson Cancer Center Houston, TX United States., Hammond D; The University of Texas MD Anderson Cancer Center Houston, TX United States., Pierce S; The University of Texas MD Anderson Cancer Center Houston, TX United States., Andreeff M; The University of Texas MD Anderson Cancer Center Houston, Tx United States., Ravandi F; The University of Texas MD Anderson Cancer Center Houston, Texas United States., Short NJ; The University of Texas MD Anderson Cancer Center Houston, TX United States., Garcia-Manero G; The University of Texas MD Anderson Cancer Center Houston, TX United States., Issa GC; The University of Texas MD Anderson Cancer Center Houston, Texas United States. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jun 22. Date of Electronic Publication: 2026 Jun 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42329225 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nguyen+D%22">Nguyen D</searchLink>; The University of Texas MD Anderson Cancer Center Houston United States.<br /><searchLink fieldCode="AU" term="%22Kantarjian+HM%22">Kantarjian HM</searchLink>; The University of Texas MD Anderson Cancer Center Houston, Tx United States.<br /><searchLink fieldCode="AU" term="%22Bidikian+A%22">Bidikian A</searchLink>; The University of Texas MD Anderson Cancer Center Houston, Tx United States.<br /><searchLink fieldCode="AU" term="%22Manuel+CM%22">Manuel CM</searchLink>; The University of Texas MD Anderson Cancer Center United States.<br /><searchLink fieldCode="AU" term="%22Qiao+W%22">Qiao W</searchLink>; The University of Texas MD Anderson Cancer Center Houston, Texas United States.<br /><searchLink fieldCode="AU" term="%22Ning+J%22">Ning J</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22DiNardo+CD%22">DiNardo CD</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Kadia+TM%22">Kadia TM</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Daver+N%22">Daver N</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Borthakur+G%22">Borthakur G</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Jabbour+E%22">Jabbour E</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Yilmaz+M%22">Yilmaz M</searchLink>; The University of Texas MD Anderson Cancer Center Houston, Texas United States.<br /><searchLink fieldCode="AU" term="%22Maiti+A%22">Maiti A</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Sasaki+K%22">Sasaki K</searchLink>; Institute of Science Tokyo Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Montalban-Bravo+G%22">Montalban-Bravo G</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Chien+K%22">Chien K</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Hammond+D%22">Hammond D</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Pierce+S%22">Pierce S</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Andreeff+M%22">Andreeff M</searchLink>; The University of Texas MD Anderson Cancer Center Houston, Tx United States.<br /><searchLink fieldCode="AU" term="%22Ravandi+F%22">Ravandi F</searchLink>; The University of Texas MD Anderson Cancer Center Houston, Texas United States.<br /><searchLink fieldCode="AU" term="%22Short+NJ%22">Short NJ</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Garcia-Manero+G%22">Garcia-Manero G</searchLink>; The University of Texas MD Anderson Cancer Center Houston, TX United States.<br /><searchLink fieldCode="AU" term="%22Issa+GC%22">Issa GC</searchLink>; The University of Texas MD Anderson Cancer Center Houston, Texas United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2026 Jun 22. <i>Date of Electronic Publication: </i>2026 Jun 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42329225 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1078-0432.CCR-26-0951 Languages: – Code: eng Text: English Titles: – TitleFull: Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nguyen D – PersonEntity: Name: NameFull: Kantarjian HM – PersonEntity: Name: NameFull: Bidikian A – PersonEntity: Name: NameFull: Manuel CM – PersonEntity: Name: NameFull: Qiao W – PersonEntity: Name: NameFull: Ning J – PersonEntity: Name: NameFull: DiNardo CD – PersonEntity: Name: NameFull: Kadia TM – PersonEntity: Name: NameFull: Daver N – PersonEntity: Name: NameFull: Borthakur G – PersonEntity: Name: NameFull: Jabbour E – PersonEntity: Name: NameFull: Yilmaz M – PersonEntity: Name: NameFull: Maiti A – PersonEntity: Name: NameFull: Sasaki K – PersonEntity: Name: NameFull: Montalban-Bravo G – PersonEntity: Name: NameFull: Chien K – PersonEntity: Name: NameFull: Hammond D – PersonEntity: Name: NameFull: Pierce S – PersonEntity: Name: NameFull: Andreeff M – PersonEntity: Name: NameFull: Ravandi F – PersonEntity: Name: NameFull: Short NJ – PersonEntity: Name: NameFull: Garcia-Manero G – PersonEntity: Name: NameFull: Issa GC IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 06 Text: 2026 Jun 22 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1557-3265 Titles: – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research Type: main |
| ResultId | 1 |